Get every episode summarized
Each time This Week in Virology publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
About this episode
Daniel Griffin provides a clinical update on COVID-19, including analysis of the dexamethasone trial, and then we discuss two Ebolavirus outbreaks in DRC, clinical and virological aspects of asymptomatic SARS-CoV-2 infections, age-dependent effects on transmission, and answer listener email.
Hosts: Vincent Racaniello, Dickson Despommier, and Alan Dove
Guests: Daniel Griffin and Chuck Knirsch
Subscribe (free): iTunes, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode
- Dexamethasone reduces COVID-19 deaths (U Oxford)
- Assessment of asymptomatic COVID-19 (Nature Med)
- Age-dependent effects on SARS-CoV-2 transmission (Nature Med)
- Image credit
- Letters read on TWiV 629
- Timestamps by Jolene. Thanks!
Intro music is by Ronald Jenkees
Send your virology questions and comments to [email protected]
Get every episode summarized
Each time This Week in Virology publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from This Week in Virology
TWiV 1358: Clinical Update with Dr. Daniel Griffin
This Week in Virology
TWiV 1357: Furin, Naturally with Paul Bieinasz
This Week in Virology
TWiV 1356: Clinical update with Dr. Daniel Griffin
This Week in Virology
TWiV 1355: Four billion years of AI training data
This Week in Virology